NCT00478179View on ClinicalTrials.gov

Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Postherpetic NeuralgiaPain

Interventions

DRUG

Transdermal/Patch (Bupivacaine TTS [Eladur™])

Trial Locations (7)

Unknown

La Jolla

Loma Linda

Santa Monica

Bradenton

Altoona

Salt Lake City

Tacoma

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Durect

INDUSTRY